Your browser doesn't support javascript.
loading
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.
Nava Rodrigues, Daniel; Rescigno, Pasquale; Liu, David; Yuan, Wei; Carreira, Suzanne; Lambros, Maryou B; Seed, George; Mateo, Joaquin; Riisnaes, Ruth; Mullane, Stephanie; Margolis, Claire; Miao, Diana; Miranda, Susana; Dolling, David; Clarke, Matthew; Bertan, Claudia; Crespo, Mateus; Boysen, Gunther; Ferreira, Ana; Sharp, Adam; Figueiredo, Ines; Keliher, Daniel; Aldubayan, Saud; Burke, Kelly P; Sumanasuriya, Semini; Fontes, Mariane Sousa; Bianchini, Diletta; Zafeiriou, Zafeiris; Teixeira Mendes, Larissa Sena; Mouw, Kent; Schweizer, Michael T; Pritchard, Colin C; Salipante, Stephen; Taplin, Mary-Ellen; Beltran, Himisha; Rubin, Mark A; Cieslik, Marcin; Robinson, Dan; Heath, Elizabeth; Schultz, Nikolaus; Armenia, Joshua; Abida, Wassim; Scher, Howard; Lord, Christopher; D'Andrea, Alan; Sawyers, Charles L; Chinnaiyan, Arul M; Alimonti, Andrea; Nelson, Peter S; Drake, Charles G.
Afiliação
  • Nava Rodrigues D; The Institute of Cancer Research, London, United Kingdom.
  • Rescigno P; The Royal Marsden, London, United Kingdom.
  • Liu D; The Institute of Cancer Research, London, United Kingdom.
  • Yuan W; The Royal Marsden, London, United Kingdom.
  • Carreira S; Department of Clinical Medicine and Surgery, Department of Translational Medical Sciences, Azienda Ospedaliera Universitaria (AOU) Federico II, Naples, Italy.
  • Lambros MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Seed G; The Broad Institute, Cambridge, Massachusetts, USA.
  • Mateo J; The Institute of Cancer Research, London, United Kingdom.
  • Riisnaes R; The Institute of Cancer Research, London, United Kingdom.
  • Mullane S; The Institute of Cancer Research, London, United Kingdom.
  • Margolis C; The Institute of Cancer Research, London, United Kingdom.
  • Miao D; The Institute of Cancer Research, London, United Kingdom.
  • Miranda S; The Royal Marsden, London, United Kingdom.
  • Dolling D; The Institute of Cancer Research, London, United Kingdom.
  • Clarke M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Bertan C; The Broad Institute, Cambridge, Massachusetts, USA.
  • Crespo M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Boysen G; The Broad Institute, Cambridge, Massachusetts, USA.
  • Ferreira A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Sharp A; The Broad Institute, Cambridge, Massachusetts, USA.
  • Figueiredo I; The Institute of Cancer Research, London, United Kingdom.
  • Keliher D; The Institute of Cancer Research, London, United Kingdom.
  • Aldubayan S; The Institute of Cancer Research, London, United Kingdom.
  • Burke KP; The Institute of Cancer Research, London, United Kingdom.
  • Sumanasuriya S; The Institute of Cancer Research, London, United Kingdom.
  • Fontes MS; The Institute of Cancer Research, London, United Kingdom.
  • Bianchini D; The Institute of Cancer Research, London, United Kingdom.
  • Zafeiriou Z; The Institute of Cancer Research, London, United Kingdom.
  • Teixeira Mendes LS; The Institute of Cancer Research, London, United Kingdom.
  • Mouw K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Schweizer MT; The Broad Institute, Cambridge, Massachusetts, USA.
  • Pritchard CC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Salipante S; The Broad Institute, Cambridge, Massachusetts, USA.
  • Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Beltran H; The Institute of Cancer Research, London, United Kingdom.
  • Rubin MA; The Institute of Cancer Research, London, United Kingdom.
  • Cieslik M; The Royal Marsden, London, United Kingdom.
  • Robinson D; The Institute of Cancer Research, London, United Kingdom.
  • Heath E; The Royal Marsden, London, United Kingdom.
  • Schultz N; The Institute of Cancer Research, London, United Kingdom.
  • Armenia J; The Royal Marsden, London, United Kingdom.
  • Abida W; The Royal Marsden, London, United Kingdom.
  • Scher H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Lord C; University of Washington, Seattle, Washington, USA.
  • D'Andrea A; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Sawyers CL; University of Washington, Seattle, Washington, USA.
  • Chinnaiyan AM; University of Washington, Seattle, Washington, USA.
  • Alimonti A; Department of Clinical Medicine and Surgery, Department of Translational Medical Sciences, Azienda Ospedaliera Universitaria (AOU) Federico II, Naples, Italy.
  • Nelson PS; Weill Medical College of Cornell University, New York, New York, USA.
  • Drake CG; Weill Medical College of Cornell University, New York, New York, USA.
J Clin Invest ; 128(10): 4441-4453, 2018 10 01.
Article em En | MEDLINE | ID: mdl-30179225

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Instabilidade de Microssatélites / Reparo de Erro de Pareamento de DNA / Antígeno B7-H1 / Imunoterapia / Mutação / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: J Clin Invest Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Instabilidade de Microssatélites / Reparo de Erro de Pareamento de DNA / Antígeno B7-H1 / Imunoterapia / Mutação / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: J Clin Invest Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido